[1]
Iqbal, A., Iqbal, U. and Abbasi, Z.A. 2022. Pembrolizumab: an unlikely cause of Type-1 Diabetes?. Journal of the Pakistan Medical Association. 72, 2 (Apr. 2022), 396–396. DOI:https://doi.org/10.47391/JPMA.4399.